Integrating Current Evidence and Individualized Treatment Regimens Into Clinical Practice for Patients With Myeloproliferative Neoplasms

Gain expert insights on the latest evidence-based strategies and emerging therapies for the management of essential thrombocythemia, polycythemia vera, and myelofibrosis with a comprehensive educational program featuring an Interactive Decision Support Tool, on-demand podcasts, and commentaries.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

GSK

Incyte Corporation

PharmaEssentia Corp